NeuroDerm Successfully Completes Enrollment and Dosing in a Phase 1 Clinical Study of ND0611 Dermal Patch for Parkinson's Disease

Jun 01, 2010, 06:59 ET from NeuroDerm Ltd

$countyNameToPathMap.put("sp